Verition Fund Management
HRMY icon

Verition Fund Management’s Harmony Biosciences HRMY Stock Holding History

Verition Fund Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,866
Closed -$388K – 2275
2026
Q1 		$388K Buy
13,866
+3,567
+35% +$117K ﹤0.01% 1681
2025
Q4 		$385K Sell
10,299
-13,479
-57% -$443K ﹤0.01% 2850
2025
Q3 		$655K Sell
23,778
-10,581
-31% -$364K ﹤0.01% 2861
2025
Q2 		$1.09M Buy
+34,359
New +$1.11M ﹤0.01% 2407
2025
Q1 		– Sell
-5,947
Closed -$205K – 3485
2024
Q4 		$205K Sell
5,947
-49,029
-89% -$1.68M ﹤0.01% 2969
2024
Q3 		$2.2M Buy
54,976
+34,524
+169% +$1.21M 0.01% 1358
2024
Q2 		$617K Buy
+20,452
New +$615K ﹤0.01% 1939
2023
Q4 		– Sell
-11,321
Closed -$371K – 2491
2023
Q3 		$371K Buy
11,321
+4,278
+61% +$149K ﹤0.01% 1605
2023
Q2 		$248K Buy
+7,043
New +$243K ﹤0.01% 1703
2021
Q4 		– Sell
-27,799
Closed -$1.07M – 2662
2021
Q3 		$1.07M Buy
+27,799
New +$895K 0.01% 899

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verition Fund Management's HRMY Position: Q2 2026 in Review

Verition Fund Management sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 13,866 shares — an estimated $388K sold.

Verition Fund Management first reported a position in HRMY in Q3 2021 and held it in 10 quarters. The position peaked at $2.2M in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Verition Fund Management reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 13,866 Harmony Biosciences shares in Q2 2026, an estimated $388K.
  • Verition Fund Management first reported a position in Harmony Biosciences in Q3 2021 and held it in 10 quarters.
  • Verition Fund Management's Harmony Biosciences position peaked at $2.2M in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.